Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.58 |
| ▸ | TSHR | P16473 | 4/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.52 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.52 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7783341 | 0.87 | CYP1A2 (0.60) | CYP1A2ALDH1A1TSHRTDP1GPR35 | |
| SCHEMBL27961047 | 0.86 | CYP1A2 (0.68) | CYP1A2ALDH1A1TSHRTDP1GPR35 | |
| SCHEMBL3124261 | 0.85 | CYP1A2 (0.67) | CYP1A2ALDH1A1TSHRTDP1GPR35 | |
| SCHEMBL9192755 | 0.85 | TSHR (0.58) | CYP1A2ALDH1A1TSHRTDP1GPR35 | |
| SCHEMBL5333075 | 0.84 | CYP1A2 (0.66) | CYP1A2ALDH1A1TSHRTDP1GPR35 | |
| SCHEMBL28379495 | 0.84 | CYP1A2 (0.57) | CYP1A2ALDH1A1TSHRTDP1GPR35 | |
| SCHEMBL30291130 | 0.83 | CYP1A2 (0.65) | CYP1A2ALDH1A1TSHRTDP1GPR35 | |
| SCHEMBL679338 | 0.83 | CYP1A2 (0.65) | CYP1A2ALDH1A1TSHRTDP1GPR35 | |
| SCHEMBL7665273 | 0.82 | CYP1A2 (0.64) | CYP1A2ALDH1A1TSHRTDP1GPR35 | |
| SCHEMBL29638033 | 0.82 | CYP1A2 (0.64) | CYP1A2ALDH1A1TSHRTDP1GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115106093-A | Preparation method and application of metal covalent organic framework catalyst | 中科澜荷(山东)新材料有限责任公司 | 2022-09-27 | — | — | CN | claimed |
| CN-115106093-B | Preparation method and application of metal covalent organic framework catalyst | 中科澜荷(山东)新材料有限责任公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-117255715-A | Catalytic material suitable for hydrogenation reactions comprising Ni, one or more additional metals M and a specific oxidation support material | 巴斯夫欧洲公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-116731727-A | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, polymer and compound | JSR株式会社 | 2023-09-12 | — | — | CN | disclosed |
| CN-115105451-B | Plant composite extract with relieving effect and preparation method and application thereof | 广州悦荟化妆品有限公司 | 2023-02-10 | — | — | CN | disclosed |
| CN-115400178-A | Anti-allergic traditional Chinese medicine composition and preparation method and application thereof | 郑州铁路职业技术学院 | 2022-11-29 | — | — | CN | disclosed |
| US-20220306677-A1 | COMPOSITIONS AND METHODS FOR MAKING HYBRID POLYPEPTIDES | YALE UNIVERSITY | 2022-09-29 | — | — | US | disclosed |
| CN-115105451-A | Plant composite extract with relieving effect, preparation method and application | 广州悦荟化妆品有限公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-115106093-A | Preparation method and application of metal covalent organic framework catalyst | 中科澜荷(山东)新材料有限责任公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-114767740-A | Preparation method of kava compound extract, compound extract and application | 广州伽能生物科技有限公司 | 2022-07-22 | — | — | CN | disclosed |
| EP-0168765-A2 | Process for the preparation of S-substituted isothio ureas | MOBAY CORPORATION (US) | 1986-01-22 | — | — | EP | disclosed |
| EP-0045129-B1 | MASKED ANTIFOGGANT COMPOUNDS FOR SILVER PHOTOGRAPHIC SYSTEMS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-09-11 | — | — | EP | disclosed |
| EP-0048999-B1 | NOVEL BETA-LACTAM COMPOUNDS, PROCESS FOR PRODUCTION THEREOF, AND MEDICINES CONTAINING THEM | Sanraku Incorporated (JP) | 1985-07-31 | — | — | EP | disclosed |
| US-4501896-A | Phenylmercaptotetrazolo- and nitroindazolo masked development/image modifiers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-02-26 | — | — | US | disclosed |
| EP-0128272-A1 | 2,4-Diaminobenzene derivates, their production and use as coupling substances | Henkel Kommanditgesellschaft auf Aktien (DE) | 1984-12-19 | — | — | EP | disclosed |
| US-4426390-A | ANTIBIOTIC | SANRAKU-OCEAN CO., LTD. (JP) | 1984-01-17 | — | — | US | disclosed |
| EP-0085407-A1 | Derivatives of antibiotics 0A-6129A, 0A-6129B1 and 0A-6129B2 and their preparation method | SANRAKU-OCEAN CO., LTD. (JP) | 1983-08-10 | — | — | EP | disclosed |
| US-4343893-A | RELEASED VIA ELECTRON TRANSFER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-08-10 | — | — | US | disclosed |
| EP-0048999-A1 | Novel beta-lactam compounds, process for production thereof, and medicines containing them | Sanraku Incorporated (JP) | 1982-04-07 | — | — | EP | disclosed |
| EP-0045129-A2 | Masked antifoggant compounds for silver photographic systems | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220306677-A1 | COMPOSITIONS AND METHODS FOR MAKING HYBRID POLYPEPTIDES | NSUN3, TARBP1, TRDMT1 | CYP1A2 4678/4885ALDH1A1 3034/4885TSHR 2920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.